Patent details

Basic Information

Publication number:

EP4243785

PCT Application Number:

IB2021060462

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP218192094

PCT Publication Number:

WO2022101828

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TALAZOPARIB SOFT GELATIN CAPSULE DOSAGE FORM

French Title of Invention:

FORME GALÉNIQUE DE CAPSULE DE GÉLATINE MOLLE DE TALAZOPARIB

German Title of Invention:

DARREICHUNGSFORM FÜR TALAZOPARIB-WEICHGELATINEKAPSEL

SPC Number:

Dates

Filing date:

11/11/2021

Grant date:

08/04/2026

EP Publication Date:

20/09/2023

PCT Publication Date:

19/05/2022

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2026

EP B1 Publication Date:

08/04/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/11/2041

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/04/2026

 

 

Name:

Pfizer Inc.

Address:

66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

1

Name:

CARMODY, Alan Francis

Address:

United Kingdom (GB)

2

Name:

PAIRET, Lydie Claude Sylvie

Address:

United Kingdom (GB)

Priority

1

Priority Number:

202063113345 P

Priority Date:

13/11/2020

Priority Country:

United States (US)

2

Priority Number:

202163276554 P

Priority Date:

05/11/2021

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/48; A61P 35/00; A61K 31/5025;

Publication

European Patent Bulletin

Issue number:

202615

Publication date:

08/04/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/11/2026

Annual Fee Number:

6

Annual Fee Amount:

66 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages